What is the primary role of Cytochrome P450 enzymes in the liver?
All are true for cytochrome P450 enzymes EXCEPT:
Phase 1 biotransformation includes
Which substance is conjugated in the liver and is the final product of heme catabolism?
Which of the following describes the first-pass metabolism?
What is the primary purpose of xenobiotic metabolism?
In the context of drug metabolism, which enzyme system is primarily responsible for the Phase I metabolism of xenobiotics?
In the metabolism of xenobiotics, which of the following reactions does not occur in phase one?
Bile salts undergo conjugation for enhanced solubility:
Which of the following separates proteins solely on the basis of their molecular size?
Explanation: ***Oxidation of drugs*** - **Cytochrome P450 enzymes** are a superfamily of monooxygenases that primarily catalyze the **oxidation of various endogenous and exogenous substrates**, including drugs [1, 2]. - This oxidative metabolism is a key step in detoxification and elimination of foreign compounds from the body [1]. *Lipid transport* - **Lipid transport** is primarily facilitated by **lipoproteins** and specific **transport proteins** in the blood and within cells. - While P450 enzymes can metabolize some lipids, their primary role is not in lipid transport [2]. *Carbohydrate synthesis* - **Carbohydrate synthesis**, or **gluconeogenesis**, is mainly carried out by enzymes such as **pyruvate carboxylase** and **fructose-1,6-bisphosphatase**. - Cytochrome P450 enzymes do not play a direct role in the synthesis of carbohydrates. *Protein degradation* - **Protein degradation** is largely mediated by the **ubiquitin-proteasome system** and **lysosomal pathways**. - Cytochrome P450 enzymes are not directly involved in breaking down proteins into smaller peptides or amino acids.
Explanation: ***Synthesize amino acids*** - Cytochrome P450 enzymes are primarily involved in the **metabolism of xenobiotics** and endogenous compounds, not in the synthesis of amino acids. - **Amino acid synthesis** occurs through different metabolic pathways involving various enzymes distinct from the cytochrome P450 system. *Involved in drug metabolism* - Cytochrome P450 enzymes are a major group of enzymes crucial for the **biotransformation of numerous drugs** and other foreign compounds. - They typically catalyze **oxidation reactions**, preparing drugs for excretion. *Present mainly in the liver* - While present in many tissues, the **highest concentration and diversity** of cytochrome P450 enzymes are found in the **liver**, which is the primary site of drug metabolism. - They are also found in the gastrointestinal tract, kidney, lung, and brain, but to a lesser extent. *Part of Phase I metabolism* - Cytochrome P450 enzymes are the **principal enzymes responsible for Phase I reactions** in drug metabolism. - **Phase I metabolism** generally involves reduction, oxidation, or hydrolysis reactions to introduce polar groups to the drug molecule.
Explanation: ***Reduction*** - **Phase 1 biotransformation reactions** are non-synthetic reactions that introduce or expose polar functional groups (e.g., -OH, -NH2, -SH) on xenobiotics to make them more water-soluble. - The three main Phase 1 reactions are **oxidation**, **reduction**, and **hydrolysis**. - These reactions typically involve **cytochrome P450 enzymes** and prepare drugs for excretion or Phase 2 conjugation. *Acetylation* - **Acetylation** is a **Phase 2 (conjugation) reaction**, not Phase 1. - Involves transfer of an acetyl group to amine-containing drugs via **N-acetyltransferase**. - Increases water solubility and facilitates excretion. *Sulfate conjugation* - **Sulfate conjugation** is a **Phase 2 (conjugation) reaction**, not Phase 1. - Involves addition of a sulfate group via **sulfotransferase enzymes**. - Significantly increases hydrophilicity for renal excretion. *Methylation* - **Methylation** is a **Phase 2 (conjugation) reaction**, not Phase 1. - Involves addition of a methyl group via **methyltransferase enzymes**. - Unlike most Phase 2 reactions, methylation may sometimes **decrease** water solubility but is still classified as conjugation.
Explanation: ***Bilirubin*** - **Bilirubin** is the primary end-product of **heme catabolism**, which largely occurs in the body's reticuloendothelial system (e.g., spleen, liver). - Unconjugated bilirubin is transported to the **liver**, where it undergoes **conjugation** with glucuronic acid, making it water-soluble for excretion in bile. *Myoglobin* - **Myoglobin** is an oxygen-binding protein found in **muscle cells**, similar to hemoglobin in red blood cells. - While it contains a heme group, it is not a direct product of heme catabolism in the same way bilirubin is, but rather a separate functional protein. *Hemoglobin* - **Hemoglobin** is the protein in red blood cells responsible for **oxygen transport**, and it contains four heme groups. - While heme is derived from hemoglobin breakdown, hemoglobin itself is the precursor to heme catabolism, not the catabolic product. *Biliverdin* - **Biliverdin** is an **intermediate product** in the catabolism of heme, formed directly from heme by the enzyme **heme oxygenase**. - It is rapidly reduced to bilirubin by **biliverdin reductase**, making bilirubin the primary end-product that undergoes further processing in the liver.
Explanation: ***Drug given orally is metabolized by the liver before entering the circulation.*** - **First-pass metabolism**, also known as **presystemic metabolism**, refers to the phenomenon where a drug is extensively metabolized in the **gastrointestinal tract** and **liver** before it reaches systemic circulation. - This process significantly reduces the **bioavailability** of orally administered drugs, as a substantial portion of the drug is inactivated or converted to metabolites before it can exert its therapeutic effect. *Drug given intravenously bypasses the liver initially.* - While intravenous (IV) administration does bypass **first-pass metabolism** in the liver and gastrointestinal tract, this statement describes what happens with IV drugs, not the first-pass metabolism itself. - IV drugs enter the **systemic circulation** directly, achieving 100% bioavailability, unlike orally administered drugs affected by first-pass metabolism. *Gastric acids primarily affect the stability of drugs.* - **Gastric acids** primarily affect the **chemical stability** and degradation of certain drugs, but this is a separate phenomenon from first-pass metabolism. - While acid degradation can reduce drug absorption, first-pass effect specifically refers to metabolic transformation in the gut wall and liver. *Absorption of a drug occurs in the intestines.* - The **small intestine** is indeed the primary site for drug absorption due to its large surface area and rich blood supply. - However, this statement describes **drug absorption** in general, not specifically the process of first-pass metabolism, which occurs *after* absorption and involves metabolism before systemic circulation.
Explanation: ***Increase water solubility*** - The primary goal of xenobiotic metabolism is to make these foreign compounds more **hydrophilic** (water-soluble). - This increased water solubility facilitates their **excretion** from the body via urine or bile. *Increase lipid solubility* - Increasing **lipid solubility** would make xenobiotics more likely to accumulate in **adipose tissue** and pass through cell membranes, hindering their excretion. - This is the opposite of the desired outcome for xenobiotic elimination. *Make them nonpolar* - Making xenobiotics **nonpolar** would be equivalent to increasing their lipid solubility, as nonpolar molecules tend to be lipid-soluble. - This would impede excretion and potentially lead to **bioaccumulation**, which is harmful. *None of the options* - This option is incorrect because xenobiotic metabolism specifically aims to increase **water solubility** for elimination.
Explanation: **Cytochrome P-450** - The **Cytochrome P-450 (CYP450) enzyme system** is a superfamily of enzymes primarily located in the liver that are crucial for Phase I **biotransformation** of xenobiotics. - Phase I reactions, which include **oxidation**, reduction, and hydrolysis, typically introduce or expose a polar functional group on the drug molecule, making it more hydrophilic and often less active. *Glutathione S-transferase* - **Glutathione S-transferases (GSTs)** are involved in **Phase II metabolism**, which involves conjugation reactions to highly polar molecules like glutathione, making compounds more water-soluble for excretion. - They play a key role in the **detoxification** of electrophilic compounds and products of oxidative stress, but not Phase I oxidation. *NADPH cytochrome P-450-reductase* - **NADPH cytochrome P-450 reductase** is an essential enzyme that **supplies electrons** to the cytochrome P-450 enzymes. - While critical for the function of CYP450, it is a **cofactor** or electron donor, not the primary enzyme system responsible for the metabolic reaction itself. *Glucuronyl transferase* - **Glucuronyl transferases (UGTs)** are involved in **Phase II metabolism**, specifically **glucuronidation**, which conjugates a drug or metabolite with glucuronic acid. - This process significantly increases the **water solubility** of the compound, facilitating its elimination from the body.
Explanation: ***Correct Answer: Conjugation*** - **Conjugation** reactions are characteristic of **Phase II metabolism**, NOT Phase I - In Phase II, a polar molecule (glucuronide, sulfate, acetyl, or glutathione) is added to the xenobiotic to increase water solubility and facilitate excretion - This process typically renders the xenobiotic inactive and more readily eliminated by the kidneys or bile - Common conjugation reactions include glucuronidation, sulfation, acetylation, and glutathione conjugation *Incorrect: Oxidation* - **Oxidation** is a primary **Phase I reaction**, primarily involving the cytochrome P450 (CYP450) enzyme system - Phase I oxidation introduces or exposes polar functional groups (-OH, -COOH, -NH2) - This makes the xenobiotic more reactive and prepares it for Phase II conjugation - Examples include hydroxylation, N-dealkylation, and O-dealkylation *Incorrect: Reduction* - **Reduction** reactions are also common in **Phase I metabolism** - Particularly important for compounds containing nitro groups, carbonyl groups, or azo compounds - These reactions can occur in various tissues, including the liver - Catalyzed by reductases such as cytochrome P450 reductase and other enzyme systems *Incorrect: Hydrolysis* - **Hydrolysis** is another key **Phase I reaction** that breaks down xenobiotics by adding water - Especially important for esters, amides, and other compounds with hydrolyzable bonds - Enzymes like esterases, amidases, and peptidases catalyze these reactions - Results in more polar metabolites that can undergo Phase II conjugation
Explanation: ***After conjugation with taurine and glycine*** - This statement accurately describes the most common conjugation pathway for bile acids, increasing their **amphipathic properties** and solubility. - Conjugation with these amino acids forms **bile salts** (e.g., glycocholate, taurocholate), which are essential for **micelle formation** and fat digestion. - This is the primary mechanism by which bile acids become bile salts with enhanced solubility. *After conjugation with betaglucuronic acid* - While bile acids do undergo conjugation for increased solubility, they are primarily conjugated with glycine or taurine, not beta-glucuronic acid. - Conjugation with beta-glucuronic acid is a common detoxification pathway for many xenobiotics and bilirubin, but not the primary method for bile acids. *After conjugation with derived proteins* - Bile salts are primarily steroid derivatives and are not conjugated with derived proteins. - The purpose of conjugation is to increase hydrophilicity, which proteins would not achieve in this context. *After conjugation with lysine* - Lysine is an amino acid but is not involved in the conjugation of bile acids. - Bile acid conjugation specifically uses the amino acids glycine and taurine.
Explanation: ***Gel filtration chromatography*** - Also known as **size-exclusion chromatography**, this method separates proteins based on their **hydrodynamic volume** (molecular size and shape). - Larger proteins pass through the column more quickly because they are excluded from the pores of the stationary phase, while smaller proteins enter the pores and have a longer, more tortuous path. *Isoelectric focusing* - This technique separates proteins based on their **isoelectric point (pI)**, which is the pH at which the protein has no net electrical charge. - Proteins migrate through a pH gradient until they reach the point where their net charge is zero. *Chromatography on a diethylaminoethyl (DEAE) cellulose column* - **DEAE cellulose** is an **anion-exchange resin**, meaning it binds **negatively charged** proteins. - Separation is based on the **net charge** of the protein at a given pH. *Chromatography on a carboxymethyl (CM) cellulose column* - **CM cellulose** is a **cation-exchange resin**, meaning it binds **positively charged** proteins. - Separation is based on the **net charge** of the protein at a given pH.
Get full access to all questions, explanations, and performance tracking.
Start For Free